JP2024513967A5 - - Google Patents
Info
- Publication number
- JP2024513967A5 JP2024513967A5 JP2023562658A JP2023562658A JP2024513967A5 JP 2024513967 A5 JP2024513967 A5 JP 2024513967A5 JP 2023562658 A JP2023562658 A JP 2023562658A JP 2023562658 A JP2023562658 A JP 2023562658A JP 2024513967 A5 JP2024513967 A5 JP 2024513967A5
- Authority
- JP
- Japan
- Prior art keywords
- target sequence
- cdl
- template
- composition
- donor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163174468P | 2021-04-13 | 2021-04-13 | |
| US63/174,468 | 2021-04-13 | ||
| PCT/US2022/024703 WO2022221467A1 (en) | 2021-04-13 | 2022-04-13 | Non-viral homology mediated end joining |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024513967A JP2024513967A (ja) | 2024-03-27 |
| JP2024513967A5 true JP2024513967A5 (https=) | 2025-04-21 |
Family
ID=83639705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562658A Pending JP2024513967A (ja) | 2021-04-13 | 2022-04-13 | 非ウイルス相同性媒介末端結合 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240240164A1 (https=) |
| EP (1) | EP4323514A4 (https=) |
| JP (1) | JP2024513967A (https=) |
| KR (1) | KR20230169221A (https=) |
| CN (1) | CN117355607A (https=) |
| AU (1) | AU2022257004A1 (https=) |
| BR (1) | BR112023021283A2 (https=) |
| CA (1) | CA3215080A1 (https=) |
| CL (2) | CL2023003030A1 (https=) |
| CO (1) | CO2023015207A2 (https=) |
| IL (1) | IL307447A (https=) |
| MX (1) | MX2023012044A (https=) |
| PE (1) | PE20231922A1 (https=) |
| WO (1) | WO2022221467A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322949A (en) | 2023-03-03 | 2025-10-01 | Arsenal Biosciences Inc | Systems targeting PSMA and CA9 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170000743A1 (en) * | 2015-07-02 | 2017-01-05 | Vindico NanoBio Technology Inc. | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles |
| US12359179B2 (en) * | 2018-12-12 | 2025-07-15 | The Regents Of The University Of California | Compositions and methods for modifying a target nucleic acid |
| CN114630910A (zh) * | 2019-06-25 | 2022-06-14 | 伊纳瑞农业技术有限公司 | 改善的同源依赖修复基因组编辑 |
-
2022
- 2022-04-13 CN CN202280036492.2A patent/CN117355607A/zh active Pending
- 2022-04-13 IL IL307447A patent/IL307447A/en unknown
- 2022-04-13 BR BR112023021283A patent/BR112023021283A2/pt unknown
- 2022-04-13 CA CA3215080A patent/CA3215080A1/en active Pending
- 2022-04-13 EP EP22788895.5A patent/EP4323514A4/en active Pending
- 2022-04-13 KR KR1020237038442A patent/KR20230169221A/ko active Pending
- 2022-04-13 WO PCT/US2022/024703 patent/WO2022221467A1/en not_active Ceased
- 2022-04-13 JP JP2023562658A patent/JP2024513967A/ja active Pending
- 2022-04-13 PE PE2023002850A patent/PE20231922A1/es unknown
- 2022-04-13 AU AU2022257004A patent/AU2022257004A1/en active Pending
- 2022-04-13 MX MX2023012044A patent/MX2023012044A/es unknown
-
2023
- 2023-10-11 CL CL2023003030A patent/CL2023003030A1/es unknown
- 2023-10-13 US US18/379,912 patent/US20240240164A1/en active Pending
- 2023-11-09 CO CONC2023/0015207A patent/CO2023015207A2/es unknown
-
2025
- 2025-05-05 CL CL2025001317A patent/CL2025001317A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| US11535871B2 (en) | Optimized gene editing utilizing a recombinant endonuclease system | |
| JP2023093658A5 (https=) | ||
| CN103224947B (zh) | 一种基因打靶系统 | |
| CN116732004A (zh) | CRISPR-Cas效应子多肽和其使用方法 | |
| CN110527697B (zh) | 基于CRISPR-Cas13a的RNA定点编辑技术 | |
| CN109136248B (zh) | 多靶点编辑载体及其构建方法和应用 | |
| BR112014014105B1 (pt) | Método para modificar um sítio-alvo predeterminado no interior de um ácido nucleico genômico ou organelar alvo em uma célula hospedeira eucariótica por um complexo núcleoproteína | |
| US20240384303A1 (en) | Genome editing method based on crispr/cas9 system and use thereof | |
| Cao et al. | The multiplexed CRISPR targeting platforms | |
| CN110577971B (zh) | CRISPR/Sa-SauriCas9基因编辑系统及其应用 | |
| CN113677793A (zh) | 稳定的crispr复合物 | |
| CA3102072A1 (en) | Gene targeting | |
| WO2023098485A1 (zh) | 一种基于c2c9核酸酶的新型基因组编辑系统及其应用 | |
| WO2023206871A1 (zh) | 一种优化的CRISPR/SpCas12f1系统、工程化向导RNA及其应用 | |
| JP2024513967A5 (https=) | ||
| WO2024125221A1 (zh) | 一种碱基编辑系统及碱基编辑方法 | |
| CN110551760B (zh) | CRISPR/Sa-SeqCas9基因编辑系统及其应用 | |
| JP7769691B2 (ja) | 新規の改良された塩基編集または編集用融合タンパク質およびその用途 | |
| KR102679001B1 (ko) | 신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도 | |
| WO2025045078A1 (zh) | 一种用于调控rna甲基化修饰的编辑系统及其应用 | |
| CN111778288A (zh) | 构建hbv转基因小鼠模型的方法、组合物和应用 | |
| CN110577969A (zh) | CRISPR/Sa-SlugCas9基因编辑系统及其应用 | |
| CN110551763B (zh) | CRISPR/SlutCas9基因编辑系统及其应用 | |
| CN110577970B (zh) | CRISPR/Sa-SlutCas9基因编辑系统及其应用 |